Group B: 188 patients who were given amikacin 15 mg / kg intramuscularly 60-120 min before the procedure. All patients underwent urinalysis and urine culture before and after the procedure. We identified post biopsy complications: bacteriuria, urinary tract infection, orchitis, pyelonephritis, sepsis, all of them were evaluated, all patients with a severe condition were hospitalized. The variables were correlated using Fishers Exact Test.
INTRODUCTION AND OBJECTIVES:
The targeted antibiotic prophylaxis by susceptible antibiotics based on the rectal swab culture has been reported to be effective for prevention of infective complications (IC) after transrectal ultrasonography guided prostate biopsy (TRPB). We evaluated the efficacy of the targeted antibiotic prophylaxis by b-lactams for the prevention of IC after TRPB among patients with quinolone-resistant (QR) strains.
METHODS: From January 2010 to December 2015, a total of 337 men who underwent TRPB were included. Prior to TRPB, rectal swabs were cultured and determined the possession of QR strains. Isolated bacteria was determined QR when their minimum inhibitory concentration of levofloxacin (LVFX) was 4 mg/mL or above. Patients were divided into two study groups. Group 1 consisted of 176 patients from January 2010 to March 2013 and group 2 consisted of 161 patients from April 2013 to December 2015. For patients without the possession of QR strains, single oral 500mg of LVFX was received 2 hours before TRPB. Patients with QR strains of the group 1 received LVFX plus amikacin and those of the group 2 received intravenous b-lactams for which isolates were susceptible. All biopsies were carried out through a standard 10-core approach with local anesthesia. The patients were followed up for 2 weeks after TRPB and febrile IC were recorded.
RESULTS: Overall the prevalence of QR strains was 13.4% (45/337). That of the group 1 and the group 2 was 9.7% (17/176) and 17.4% (28/161), respectively. A total of 14 patients (4.2%) had post-TRPB fever in this study. The incidence of febrile IC of the group 1 was 1.7% (3/176) and that of the group 2 was 6.8% (11/161). Forty-five patients with QR strains were complied with targeted antibiotic prophylaxis. In the group 1, only one (5.9%) out of 17 patients with QR strains had febrile IC. In the group 2, although they received b-lactam antibiotics which were susceptible to isolates from rectal swab culture, 8 (28.6%) out of 28 patients with QR strains had febrile IC.
CONCLUSIONS: In the group 1, few patients with both quinolone-sensitive and QR strains had febrile IC. In the group 2, the incidence of febrile IC has increased, especially among patients with QR strains who received susceptible b-lactams for prophylaxis. The targeted antibiotic prophylaxis by b-lactams alone was less effective among patients with QR strains. Facing the increase of multi-drug resistant bacteria in the rectal flora, new tactics to prevent post-TRPB febrile IC will be needed. CONCLUSIONS: This study demonstrates the translocation of gut endotoxin post TRPB. The non portal venous drainage of the prostate is an explanation for the endotoxins measured after biopsy. These findings of endotoxaemia are in keeping with the landmark studies previously performed that demonstrated endotoxin in the unprotected placebo group. The Prostate, Lung, Colorectal and Ovary (PLCO) study reported a mortality rate at 120 days post TRPB of 1.3 deaths per 1,000 biopsies in the negative biopsy group. This compares with the risk reported by Gallina et al in a population-based study, with overall 120-day mortality after biopsy of 1.3% versus 0.3% in the control group. A review of cardiac complications after pneumonia showed a significant increase in cardiac mortality. The effect of circulating inflammatory mediators such as endotoxins leading to non-ischaemic myocardial injury is proposed as one of the potential mechanisms contributing to myocardial dysfunction. This study raises several issues. What is the significance of endotoxin detection in the serum samples after prostate biopsy? Is this related to the increased mortality in relation to cardiovascular dysfunction of this group? The WHO's Global Action Plan on Antimicrobial Resistance in 2015 emphasises that we have a duty of governance and stewardship to review the implementation of alternative surgical approaches that will allow limitation of antibiotic prophylaxis in TRPB. While we endeavour to understand the clinical significance of the association between bacteraemia and endotoxaemia after transrectal prostate biopsy it is important that we share with the patients the worldwide risks of the procedure as we strive to make prostate biopsy safer.
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